IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Independent data review commences for Ph 2 trial psilocybin, page-17

  1. 1,081 Posts.
    lightbulb Created with Sketch. 117
    Really positive announcement with no adverse effects so far, which for anxiety medications especially are an issue. Nothing major to go on with how it went but seems positive, these drugs would be multi-billions if they pull it off and more importantly help so many people.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.